Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T T Chang

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Gastroenterology|July 13, 2000
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study GroupY F Liaw, N W Leung, T T Chang, et al.
Journal of Gastroenterology and Hepatology|March 1, 1994
Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosisH C Meng, H C Lin, Y T Tsai, et al.
Journal of Clinical Microbiology|November 4, 2000
Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemicC C Lin, J C Wu, T T Chang, et al.
Leukemia|February 20, 1999
Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology GroupD C Liang, I J Hung, C P Yang, et al.
Journal of Viral Hepatitis|June 26, 2003
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in TaiwanY-H Huang, J-C Wu, T-T Chang, et al.
Liver|June 1, 1996
Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testingT T Chang, K C Young, Y J Yang, et al.
Clinical Pharmacology and Therapeutics|October 1, 1988
The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascitesC S Lay, Y T Tsai, C W Kong, et al.
Journal of Viral Hepatitis|April 27, 2005
Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in TaiwanS-D Lee, M-L Yu, P-N Cheng, et al.
Journal of Gastroenterology and Hepatology|February 24, 2001
Status and natural course of GB virus C/hepatitis G virus infection among high-risk groups and volunteer blood donors in TaiwanM L Yu, W L Chuang, L Y Wang, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapyN W Leung, C L Lai, T T Chang, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Gastroenterology|July 13, 2000
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study GroupY F Liaw, N W Leung, T T Chang, et al.
Journal of Gastroenterology and Hepatology|March 1, 1994
Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosisH C Meng, H C Lin, Y T Tsai, et al.
Journal of Clinical Microbiology|November 4, 2000
Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemicC C Lin, J C Wu, T T Chang, et al.
Leukemia|February 20, 1999
Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: a report from the Taiwan Pediatric Oncology GroupD C Liang, I J Hung, C P Yang, et al.
Journal of Viral Hepatitis|June 26, 2003
Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B patients in TaiwanY-H Huang, J-C Wu, T-T Chang, et al.
Liver|June 1, 1996
Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testingT T Chang, K C Young, Y J Yang, et al.
Clinical Pharmacology and Therapeutics|October 1, 1988
The influence of verapamil and nifedipine on hepatic indocyanine green clearance in patients with HBsAg-positive cirrhosis and ascitesC S Lay, Y T Tsai, C W Kong, et al.
Journal of Viral Hepatitis|April 27, 2005
Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in TaiwanS-D Lee, M-L Yu, P-N Cheng, et al.
Journal of Gastroenterology and Hepatology|February 24, 2001
Status and natural course of GB virus C/hepatitis G virus infection among high-risk groups and volunteer blood donors in TaiwanM L Yu, W L Chuang, L Y Wang, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapyN W Leung, C L Lai, T T Chang, et al.
Pageof 12